Patents by Inventor Federica Cavallo

Federica Cavallo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220213187
    Abstract: Certain embodiments are directed to therapeutic compositions having an xCT specific antibody.
    Type: Application
    Filed: May 8, 2020
    Publication date: July 7, 2022
    Inventors: FEDERICA CAVALLO, AHMAD SALAMEH, JERRI CALDEIRA, FEDERICA PERICLE
  • Patent number: 11059901
    Abstract: Certain embodiments are directed to therapeutic compositions having an xCT specific antibody.
    Type: Grant
    Filed: April 30, 2018
    Date of Patent: July 13, 2021
    Assignee: Agilvax Inc.
    Inventors: Federica Pericle, John O′Rourke, Federica Cavallo
  • Patent number: 11040223
    Abstract: Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: June 22, 2021
    Assignee: Agilvax Inc.
    Inventors: Federica Cavallo, Stefania Lanzardo, Laura Conti, John P. O'Rourke, Federica Pericle
  • Patent number: 10849967
    Abstract: A nucleic acid molecule encoding a chimeric chondroitin sulfate proteoglycan 4 (CSPG4) protein, wherein the chimeric CSPG4 protein comprises, from the N-terminal to the C-terminal: i) a first portion derived from the human CSPG4 sequence and a second portion derived from the canine CSPG4 sequence or ii) a first portion derived from the canine CSPG4 sequence and a second portion derived from the human CSPG4 sequence.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: December 1, 2020
    Assignee: Università degli Studi di Torino
    Inventors: Federica Cavallo, Paolo Buracco, Federica Riccardo, Maddalena Arigoni, Elena Quaglino, Raffaele Adolfo Calogero, Soldano Ferrone
  • Publication number: 20200316147
    Abstract: Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.
    Type: Application
    Filed: March 16, 2020
    Publication date: October 8, 2020
    Inventors: Federica CAVALLO, Stefania LANZARDO, Laura CONTI, John P. O'ROURKE, Federica PERICLE
  • Publication number: 20200148784
    Abstract: Certain embodiments are directed to therapeutic compositions having an xCT specific antibody.
    Type: Application
    Filed: April 30, 2018
    Publication date: May 14, 2020
    Inventors: Federica PERICLE, John O'ROURKE, Federica CAVALLO
  • Patent number: 10588953
    Abstract: Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.
    Type: Grant
    Filed: December 18, 2016
    Date of Patent: March 17, 2020
    Assignee: AGILVAX, INC.
    Inventors: Federica Cavallo, Stefania Lanzardo, Laura Conti, John P. O'Rourke, Federica Pericle
  • Publication number: 20190008940
    Abstract: A nucleic acid molecule encoding a chimeric chondroitin sulfate proteoglycan 4 (CSPG4) protein, wherein the chimeric CSPG4 protein comprises, from the N-terminal to the C-terminal: i) a first portion derived from the human CSPG4 sequence and a second portion derived from the canine CSPG4 sequence or ii) a first portion derived from the canine CSPG4 sequence and a second portion derived from the human CSPG4 sequence.
    Type: Application
    Filed: December 28, 2016
    Publication date: January 10, 2019
    Inventors: Federica CAVALLO, Paolo BURACCO, Federica RICCARDO, Maddalena ARIGONI, Elena QUAGLINO, Raffaele Adolfo CALOGERO, Soldano FERRONE
  • Publication number: 20180360935
    Abstract: Certain embodiments are directed to composition for inducing an immune response against xCT that is directed to cancer stem cells expressing xCT.
    Type: Application
    Filed: December 18, 2016
    Publication date: December 20, 2018
    Inventors: Federica CAVALLO, Stefania LANZARDO, Laura CONTI, John P. O'ROURKE, Federica PERICLE
  • Patent number: 8389494
    Abstract: Methods for inhibiting the formation and growth of a p185neu positive tumor in a subject, and for treating a subject having a p185neu positive tumor, utilizing a DNA vector coding for a chimeric rat/human Her-2/neu/ErbB-2 protein are provided.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: March 5, 2013
    Assignee: Indena S.p.A.
    Inventors: Augusto Amici, Federica Cavallo, Guido Forni, Cristina Marchini
  • Patent number: 8298821
    Abstract: Plasmids containing sequences encoding different fragments of p185neu oncoprotein, able to induce an immune response against tumours expressing oncogenes of the ErbB family, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: September 2, 2010
    Date of Patent: October 30, 2012
    Assignee: Indena S.p.A.
    Inventors: Augusto Amici, Federica Cavallo, Guido Forni, Cristina Marchini
  • Patent number: 8207141
    Abstract: DNA plasmids containing sequences coding for different fragments of 185neu oncoprotein which are able to induce an immune response against p185neu-overexpressing tumors, and pharmaceutical compositions thereof are described.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: June 26, 2012
    Inventors: Augusto Amici, Cristina Marchini, Elena Quaglino, Federica Cavallo, Guido Forni
  • Publication number: 20110256162
    Abstract: DNA plasmids containing sequences coding for different fragments of 185neu oncoprotein which are able to induce an immune response against p185neu-overexpressing tumors, and pharmaceutical compositions thereof are described.
    Type: Application
    Filed: June 30, 2011
    Publication date: October 20, 2011
    Inventors: Augusto Amici, Cristina Marchini, Elena Quaglino, Federica Cavallo, Guido Forni
  • Patent number: 7985582
    Abstract: DNA plasmids containing sequences coding for different fragments of 185neu oncoprotein which are able to induce an immune response against p185neu-overexpressing tumors, and pharmaceutical compositions thereof are described.
    Type: Grant
    Filed: October 13, 2005
    Date of Patent: July 26, 2011
    Inventors: Augusto Amici, Cristina Marchini, Elena Quaglino, Federica Cavallo, Guido Forni
  • Patent number: 7795016
    Abstract: Plasmids containing sequences encoding different fragments of p185neu oncoprotein, able to induce an immune response against tumours expressing oncogenes of the ErbB family, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: October 6, 2004
    Date of Patent: September 14, 2010
    Assignee: Indena S.p.A.
    Inventors: Augusto Amici, Federica Cavallo, Guido Forni, Cristina Marchini
  • Publication number: 20090214577
    Abstract: DNA plasmids containing sequences coding for different fragments of 185neu oncoprotein which are able to induce an immune response against p185neu-overexpressing tumors, and pharmaceutical compositions thereof are described.
    Type: Application
    Filed: October 13, 2005
    Publication date: August 27, 2009
    Inventors: Augusto Amici, Cristina Marchini, Elena Quaglino, Federica Cavallo, Guido Forni